Navigation Links
Guidelines Suggested for Heart-Kidney Transplants
Date:3/18/2009

Study identifies factors that reduce survival rate for combo surgery,,,,

WEDNESDAY, March 18 (HealthDay News) -- A set of criteria to help identify people who would benefit from a combined heart and kidney transplant has been developed by U.S. researchers.

"In the past, patients with end-stage heart failure having concurrent renal (kidney) disease were not considered candidates for heart transplantation," Dr. Mark J. Russo, of Columbia University Medical Center/New York Presbyterian Hospital, and colleagues noted in the study. "With advances in operative techniques and perioperative (around the time of surgery) management, combined heart and kidney transplantation is offered to select patients in this population."

However, there are no standardized guidelines for heart and kidney transplants.

The researchers analyzed data from 274 people who had combined heart and kidney transplants between 1995 and 2005. Pre-transplant factors that reduced survival were: peripheral vascular disease (disease of blood vessels outside the heart and brain); being older than 65; heart failure that was non-ischemic, meaning it was not caused by blocked or narrowed arteries; and dependence on dialysis or a pumping device that assists the heart as a bridge to transplantation.

When people were grouped according to these risk factors, the one-year survival rate was about 93 percent for those in the lowest-risk group and 62 percent for those with the greatest risk.

About a fourth of the highest-risk patients died from infection. The study found that people older than 65, those with peripheral artery disease and those bridged to transplantation with a pumping-assist device appeared more vulnerable to infection, which explained their increased risk of death. But it was not clear why people with non-ischemic heart failure also had a high risk of death, the researchers said.

"Among patients with combined kidney failure (estimated glomerular filtration rate less than 33 milliliters per minute) and heart failure, those classified by this risk stratification scheme as low-risk should undergo combined heart and kidney transplantation, while there is no demonstrable benefit for combined heart and kidney transplantation over heart transplantation alone in patients classified as high risk," they concluded.

The study is in the March issue of Archives of Surgery.

More information

The National Kidney Foundation has more about kidney transplantation.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, March 16, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. EAU launches new clinical guidelines for 2009 -- kidney cancer
2. Emprise 7000 Storage System, with ICON Manager and Virtual View Integration, Helps Milliman Care Guidelines Simplify Storage Management
3. CIMRO of Nebraska Uses Milliman Care Guidelines(R) for Nebraska Medicare Reviews
4. Experts Revise Guidelines on Daily Aspirin for Heart
5. NCCN Presents Updates to NCCN Guidelines for Thyroid Carcinoma
6. Early Detection Remains Key in Updated NCCN Guidelines for Ovarian Cancer
7. New NCCN Guidelines for Primary Cutaneous B-Cell Lymphoma and Updates to NCCN Guidelines for Non-Hodgkins Lymphomas
8. NCCN Announces Updates to Pancreatic Adenocarcinoma Guidelines
9. The REACH Institute: Best Practice Guidelines Address Mental Health Needs of Youth in Care
10. New Book Exposes Junk Science, Conflicts of Interest, Disease Guidelines Affecting Millions
11. IPRO QIO Uses Milliman Care Guidelines(R) for Medicare Reviews in New York State
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Guidelines Suggested for Heart-Kidney Transplants
(Date:8/17/2017)... MA (PRWEB) , ... August 17, 2017 , ... ... home care professionals, today announced that it has raised $1.675 M in seed ... , Rethink Education, Lumina Foundation, and Techstars Venture Capital Fund are the company’s ...
(Date:8/17/2017)... ... 2017 , ... Advice Media, the industry leader in digital marketing for medical practices, has been ... been included in the Inc. 5000 for the second time in two years. Shawn Miele, ... Inc. 5000 rankings for the second year in a row. It’s extremely difficult to make ...
(Date:8/17/2017)... ... August 17, 2017 , ... Navigating ... a Florida-based oncology business advisor to oncology practices, announced today the results of ... of attributable savings from resolving critical clinical issues that would have otherwise resulted ...
(Date:8/16/2017)... , ... August 16, 2017 , ... An August 3rd article on Reuters ... subject of a report in JAMA (the Journal of the American Medical Association). The study ... able to achieve BMIs under 30, when compared to patients with lower BMIs. At present, ...
(Date:8/16/2017)... GA (PRWEB) , ... August 16, 2017 , ... ... new Inc. 5000. The company ranked #4429 on the newly released, 36th annual ... list represents a unique look at the most successful companies within the American economy’s ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... Aug. 7, 2017 Insightin Health, provider ... retention, and engagement, announced the selection of ... Product Development, effective as of February 2017. In this ... implementation strategy for our clients. Wood brings with ... consulting and business analytics within the healthcare industry. ...
(Date:8/7/2017)... Aug. 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the ... quarter ended June 30, 2017.  All comparisons, unless otherwise noted, ... Second Quarter 2017 Highlights include: ... $1,089 million, an increase of 3.5% Total ... Gross margin of 7.5% versus 7.6% ...
(Date:8/4/2017)...  Agragen, LLC, a Cincinnati ... nutraceutical, and aquacultural feed sectors, announces a significant ... candidates, AGR131.  This drug is designed to trap ... of patients suffering from inflammatory conditions such as ... Biological pharmaceuticals currently ...
Breaking Medicine Technology: